1220.6000 -49.70 (-3.91%)
NSE Aug 01, 2025 15:31 PM
Volume: 2.5M
 

1220.60
-3.91%
DR REDDYS LTD.
Joindre Capital Services
However, Indian business showed steady growth & North America posted modest growth which includes Habitrol sales for full quarter. Emerging markets posted strong growth on back of higher contribution from Venezuela. EBIDTA grew by 9.7% YoY to Rs.832crs & EBITDA margin stood at 21.5% contracted sequentially mainly on account of lower gross margins due to vScore: vScore (Value Score) is our proprietary company rating system f...
Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended